Fennec Pharmaceuticals (FENC) Assets Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.56% |
| Sep 30, 2025 | 7.65% |
| Jun 30, 2025 | 2.68% |
| Mar 31, 2025 | 34.95% |
| Dec 31, 2024 | 26.01% |
| Sep 30, 2024 | 29.94% |
| Jun 30, 2024 | 28.78% |
| Mar 31, 2024 | 27.35% |
| Dec 31, 2023 | 3.20% |
| Sep 30, 2023 | -4.34% |
| Jun 30, 2023 | -5.44% |
| Mar 31, 2023 | -4.05% |
| Dec 31, 2022 | -1.05% |
| Sep 30, 2022 | 25.20% |
| Jun 30, 2022 | 8.70% |
| Mar 31, 2022 | 42.25% |
| Dec 31, 2021 | 41.35% |
| Sep 30, 2021 | 41.54% |
| Jun 30, 2021 | 40.67% |
| Mar 31, 2021 | 116.28% |
| Dec 31, 2020 | 98.52% |
| Sep 30, 2020 | 88.02% |
| Jun 30, 2020 | 83.87% |
| Mar 31, 2020 | 39.69% |
| Dec 31, 2019 | 42.92% |
| Sep 30, 2019 | 88.24% |
| Jun 30, 2019 | 76.23% |
| Mar 31, 2019 | 71.43% |
| Dec 31, 2018 | 67.28% |
| Sep 30, 2018 | 108.03% |
| Jun 30, 2018 | 90.30% |
| Mar 31, 2018 | 69.15% |
| Dec 31, 2017 | 64.40% |
| Sep 30, 2017 | 27.54% |
| Jun 30, 2017 | 23.30% |
| Mar 31, 2017 | -7.12% |
| Dec 31, 2016 | -5.79% |
| Sep 30, 2016 | -6.09% |
| Jun 30, 2016 | -5.66% |
| Dec 31, 2015 | -29.84% |